Format

Send to

Choose Destination
Br J Cancer. 1997;76(7):852-4.

Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy.

Author information

1
Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115, USA.

Abstract

The NAD(P)H quinone oxidoreductase (NQO1:EC 1.6.99.2) is an important biotransformation enzyme system that is also known to metabolize important novel chemotherapeutic compounds. The gene that codes for this enzyme has recently been found to be polymorphic in humans. Here, we describe the ethnic distribution of the polymorphism and note that this may have implications for anti-tumour drug development and use.

PMID:
9328142
PMCID:
PMC2228056
DOI:
10.1038/bjc.1997.474
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center